Lumboperitoneal Shunt Placement

Lumboperitoneal Shunt Placement

No Results

No Results

processing….

Placement of a lumboperitoneal shunt is an effective method to divert spinal fluid. Two general types of lumboperitoneal shunts are in use today: valve-mediated and valveless types. The placement techniques described below are common to both.

Lumboperitoneal shunting is a method of diverting cerebrospinal fluid (CSF) from the subarachnoid space to the abdominal cavity. Advantages of lumboperitoneal shunting include avoidance of brain penetration with the shunt catheter, access to a large CSF space in the thecal sac, and the potential (for good or ill) of a large amount of CSF drainage.

Patients who require a lumboperitoneal shunt have pathology that predisposes to obstruction of CSF absorption or elevated CSF pressure but must have communication of the spinal CSF with the cranial compartment. Specific indications include, but are not limited to, communicating hydrocephalus, normal pressure hydrocephalus, and idiopathic intracranial hypertension (pseudotumor cerebri). [1, 2, 3, 4, 5]

Lumboperitoneal shunts can also be placed for management of localized pathology that affects the spinal cord. They have been used to drain and prevent reformation of pseudomeningoceles, or unwanted collections of CSF. Lumboperitoneal shunts have also been used to help minimize CSF leaks, either natural or iatrogenic. The principle is to decrease the fluid pressure on the dural defect and thus prevent excessive CSF leakage. Its use in the treatment of spinal syringomyelia has also been reported. [6]

A lumboperitoneal shunt should not be placed in patients with localized elevated pressure and mass effect in the cranial cavity (eg, intracranial tumor or subdural hematoma). Excessive shunting of CSF in the spine may create a pressure gradient across the craniospinal junction, promoting downward brain herniation. A Chiari malformation is a relative contraindication to lumbar shunting for this reason. In addition, the spinal CSF space must freely communicate with the cranial CSF space.

Lumboperitoneal shunt complications can be divided into those involving the lumbar catheter, those involving the peritoneal catheter, and general complications. Valve complications can also exist if a catheter system with a valve is installed.

Lumbar catheter complications include overdrainage of CSF, catheter obstruction, catheter migration, catheter misplacement, and spinal nerve irritation. [1, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24] Overdrainage of CSF is a commonly cited complication; symptoms generally involve postural headaches, nausea, and vomiting. More severe manifestations of overdrainage, acquired Arnold Chiari displacements and subdural hematomas, have been reported. To reduce the incidence of overdrainage, some surgeons advocate the use of valved-shunt systems. Valved systems allow a fixed volume of CSF to be drained into the peritoneal cavity, or drainage against a fixed pressure (see below).

As the lumboperitoneal catheter is placed in close proximity to the spinal nerves, spinal nerve injury or radiculopathy can occur. In general, the needle should not be placed above the L3 level to avoid potentially injuring the spinal cord. As the patient is in the lateral decubitus position, the Tuohy needle should be inserted with the sharp up-curving end of the needle in parallel to the patient’s longitudinal axis. Once placement of the needle is confirmed, the Tuohy needle should be rotated 90º to allow the catheter to be fed in a rostral or caudal direction. Multiple attempts at spinal puncture can lead to a postoperative CSF leak. Fluoroscopy can be used intraoperatively to aid in placement.

Catheter migration within the spinal and peritoneal compartment is common. Preventive steps involve using sutures and anchors (usually provided with the shunt system) to secure the spinal catheter in place to the lumbar fascia after proper intraoperative placement. Nonetheless, reports of migration have been reported despite securing the catheter. [17, 18, 23, 24, 25]

Shunt infections [1, 7, 9, 25] are not as common in adult patients as are shunt displacements. Steps to prevent infection include proper preoperative surgical site disinfection, careful draping (consider glove change after draping), and minimizing operating time. Systemic antibiotics should also be given within one hour prior to skin incision. The catheter system can be stored in an antibiotic solution prior to insertion but generally is not opened until ready for use.

Blockage of the shunt system, resulting in failure of the system, can occur. The reported incidence of shunt revision due to obstruction ranges from 14%-62%. The incidence of shunt infection and resulting meningitis ranges from 1%-10% of all lumboperitoneal shunts. Shunt infection can also result in shunt obstruction. [1, 8, 9, 26]

Migration of the shunt catheters is also a common experience. The lumbar catheter can migrate relative to the thecal sac (usually into the subcutaneous space), and the peritoneal catheter can likewise come out of the peritoneum. The incidence ranges from 3%-20%. Migration complications have been noted to be more common in the pediatric population. [8, 26, 27] When a catheter migrates out of the thecal sac, a subcutaneous collection of spinal fluid can be observed.

Newly onset radicular pain has been noted to occur with lumboperitoneal shunts. This may result from catheter migration or localized inflammation leading to arachnoiditis. The onset of symptoms may necessitate shunt revision. The incidence of developing newly onset radicular pain ranges from 5%-6%. [1, 26]

Overdrainage of CSF can result in intracranial hypotension and positional headaches. Incidence has been noted to be from 5%-10%. [25, 27] Valves have been designed to trigger at different pressures in the recumbent and standing position (see below), and programmable valves are also available. In one case report, authors report overdrainage secondary to an iatrogenic dural defect when placing the lumbar section of the shunt. [16] On the other hand, underdrainage without relief of preoperative symptoms is also possible. Incidence can range from 9%-12%. [8]

Intracerebral hemorrhages and secondary Arnold Chiari-type tonsillar herniation have been reported. The incidence of postprocedure subdural hematomas ranges from 2%-4%. [1, 9] Isolated case reports of intraparenchymal hemorrhages, as well as abdominal hemorrhages that occur after shunt placement, have also been reported. [21, 22] The incidence of Arnold-Chiari 1 displacements have been reported to occur in up to 70% of patients. However, only a smaller subset of patients, 1%-14%, have been described to develop symptoms. [2] Interestingly, associated scoliosis has also been reported. [14]

Aoki N. Lumboperitoneal shunt: clinical applications, complications, and comparison with ventriculoperitoneal shunt. Neurosurgery. 1990 Jun. 26(6):998-1003; discussion 1003-4. [Medline].

Uretsky S. Surgical interventions for idiopathic intracranial hypertension. Curr Opin Ophthalmol. 2009 Nov. 20(6):451-5. [Medline].

Garton HJ. Cerebrospinal fluid diversion procedures. J Neuroophthalmol. 2004 Jun. 24(2):146-55. [Medline].

Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia. 2008 Dec. 28(12):1361-73. [Medline].

Chang CC, Kuwana N, Ito S. Management of patients with normal-pressure hydrocephalus by using lumboperitoneal shunt system with the Codman Hakim programmable valve. Neurosurg Focus. 1999 Oct 15. 7(4):e8. [Medline].

Oluigbo CO, Thacker K, Flint G. The role of lumboperitoneal shunts in the treatment of syringomyelia. J Neurosurg Spine. 2010 Jul. 13(1):133-8. [Medline].

Wang VY, Barbaro NM, Lawton MT, Pitts L, Kunwar S, Parsa AT, et al. Complications of lumboperitoneal shunts. Neurosurgery. 2007 Jun. 60(6):1045-8; discussion 1049. [Medline].

Chumas PD, Kulkarni AV, Drake JM, Hoffman HJ, Humphreys RP, Rutka JT. Lumboperitoneal shunting: a retrospective study in the pediatric population. Neurosurgery. 1993 Mar. 32(3):376-83; discussion 383. [Medline].

Duthel R, Nuti C, Motuo-Fotso MJ, Beauchesne P, Brunon J. [Complications of lumboperitoneal shunts. A retrospective study of a series of 195 patients (214 procedures)]. Neurochirurgie. 1996. 42(2):83-9; discussion 89-90. [Medline].

Chumas PD, Armstrong DC, Drake JM, Kulkarni AV, Hoffman HJ, Humphreys RP, et al. Tonsillar herniation: the rule rather than the exception after lumboperitoneal shunting in the pediatric population. J Neurosurg. 1993 Apr. 78(4):568-73. [Medline].

Chumas PD, Drake JM, Del Bigio MR. Death from chronic tonsillar herniation in a patient with lumboperitoneal shunt and Crouzon’s disease. Br J Neurosurg. 1992. 6(6):595-9. [Medline].

Turkoglu E, Kazanci B, Karavelioglu E, Sanli M, Kazanci B, Sekerci Z. Intracerebral hematoma following lumboperitoneal shunt insertion: a rare case report. Turk Neurosurg. 2011 Jan. 21(1):94-6. [Medline].

Bunc G, Vorsic M, Ravnik J, Velnar T. Proximal migration of a lumboperitoneal shunt into the prepontine and ambiens cisterns. Clin Neurol Neurosurg. 2011 Jan. 113(1):75-7. [Medline].

Chen HH, Chang FC, Wong TT. Scoliosis and syringomyelia with Chiari malformation after lumbar shunting. J Chin Med Assoc. 2010 Jul. 73(7):384-8. [Medline].

Riffaud L, Moughty C, Henaux PL, Haegelen C, Morandi X. Acquired Chiari I malformation and syringomyelia after valveless lumboperitoneal shunt in infancy. Pediatr Neurosurg. 2008. 44(3):229-33. [Medline].

Liao YJ, Dillon WP, Chin CT, McDermott MW, Horton JC. Intracranial hypotension caused by leakage of cerebrospinal fluid from the thecal sac after lumboperitoneal shunt placement. Case report. J Neurosurg. 2007 Jul. 107(1):173-7. [Medline].

Solaroglu I, Okutan O, Beskonakli E. Foraminal migration of a lumboperitoneal shunt catheter tip. J Clin Neurosci. 2005 Nov. 12(8):956-8. [Medline].

Rodrigues D, Nannapaneni R, Behari S, Prasad M, Herwadkar A, Gerber CJ, et al. Proximal migration of a lumboperitoneal unishunt system. J Clin Neurosci. 2005 Sep. 12(7):838-41. [Medline].

Karabatsou K, Quigley G, Buxton N, Foy P, Mallucci C. Lumboperitoneal shunts: are the complications acceptable?. Acta Neurochir (Wien). 2004 Nov. 146(11):1193-7. [Medline].

Kamiryo T, Hamada J, Fuwa I, Ushio Y. Acute subdural hematoma after lumboperitoneal shunt placement in patients with normal pressure hydrocephalus. Neurol Med Chir (Tokyo). 2003 Apr. 43(4):197-200. [Medline].

Suri A, Pandey P, Mehta VS. Subarachnoid hemorrhage and intracereebral hematoma following lumboperitoneal shunt for pseudotumor cerebri: a rare complication. Neurol India. 2002 Dec. 50(4):508-10. [Medline].

Samandouras G, Wadley J, Afshar F. Life-threatening intra-abdominal haemorrhage following insertion of a lumboperitoneal shunt. Br J Neurosurg. 2002 Apr. 16(2):192-3. [Medline].

Satow T, Motoyama Y, Yamazoe N, Isaka F, Higuchi K, Nabeshima S. Migration of a lumboperitoneal shunt catheter into the spinal canal–case report. Neurol Med Chir (Tokyo). 2001 Feb. 41(2):97-9. [Medline].

Carroll TA, Jakubowski J. Intrathecal migration of a lumboperitoneal shunt. Br J Neurosurg. 2000 Oct. 14(5):496-7. [Medline].

Rekate HL, Wallace D. Lumboperitoneal shunts in children. Pediatr Neurosurg. 2003 Jan. 38(1):41-6. [Medline].

Eisenberg HM, Davidson RI, Shillito J Jr. Lumboperitoneal shunts. Review of 34 cases. J Neurosurg. 1971 Oct. 35(4):427-31. [Medline].

Spetzler RF, Wilson CB, Grollmus JM. Percutaneous lumboperitoneal shunt. Technical note. J Neurosurg. 1975 Dec. 43(6):770-3. [Medline].

Allmond LR, Stratmann G, Kunwar SM, Burkhardt DH. Epidural blood patch for headache after lumboperitoneal shunt placement. Anesth Analg. 2005 Nov. 101(5):1497-8. [Medline].

Aoki N. Lumboperitoneal shunt for the treatment of postoperative persistent collection of subcutaneous cerebrospinal fluid (pseudomeningocoele). Acta Neurochir (Wien). 1989. 98(1-2):32-4. [Medline].

Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997 Sep. 49(3):734-9. [Medline].

Nadkarni TD, Rekate HL, Wallace D. Concurrent use of a lumboperitoneal shunt with programmable valve and ventricular access device in the treatment of pseudotumor cerebri: review of 40 cases. J Neurosurg Pediatr. 2008 Jul. 2(1):19-24. [Medline].

Chih-Ta Lin, MD Resident Physician, Division of Neurosurgery, Fletcher Allen Health Care, University of Vermont College of Medicine

Chih-Ta Lin, MD is a member of the following medical societies: American Association for Cancer Research, American Association of Neurological Surgeons, American College of Surgeons, Society for Neuro-Oncology, Congress of Neurological Surgeons

Disclosure: Nothing to disclose.

Paul L Penar, MD, FACS Professor, Department of Surgery, Division of Neurosurgery, Director, Functional Neurosurgery and Radiosurgery Programs, University of Vermont College of Medicine

Paul L Penar, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, World Society for Stereotactic and Functional Neurosurgery, Congress of Neurological Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Remi Nader, MD, CM, FRCS(C), FACS, FAANS President, Texas Center for Neurosciences PLLC; Clinical Associate Professor of Neurosurgery, University of Texas Medical Branch at Galveston; Clinical Assistant Professor of Neurosurgery, Department of Neurosurgery, Tulane University School of Medicine

Remi Nader, MD, CM, FRCS(C), FACS, FAANS is a member of the following medical societies: American Association of Neurological Surgeons, American College of Surgeons, Royal College of Physicians and Surgeons of Canada

Disclosure: Received consulting fee from Alliance Partners for consulting; Received consulting fee from Medyssey Spine for consulting.

Lumboperitoneal Shunt Placement

Research & References of Lumboperitoneal Shunt Placement|A&C Accounting And Tax Services
Source